| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4170895 | Paediatric Respiratory Reviews | 2013 | 7 Pages |
Abstract
SummaryAsthma is usually treated with inhaled corticosteroids (ICS) and bronchodilators generated from pressurized metered dose inhalers (pMDI), dry powder inhalers (DPI), or nebulizers. The target areas for ICS and beta 2-agonists in the treatment of asthma are explained. Drug deposition not only depends on particle size, but also on inhalation manoeuvre. Myths regarding inhalation treatments lead to less than optimal use of these delivery systems. We discuss the origin of many of these myths and provide the background and evidence for rejecting them.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Bart L. Rottier, Bruce K. Rubin,